3 completed. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 3 |
Follow Angiomyolipoma: new trials by email Literature Review of Angiomyolipoma trials Research Report on Angiomyolipoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML) Everolimus - Renal Angiomyolipoma | Phase 4 | Completed | Novartis Pharmaceuticals | 10 | 2023-05-01 | 2026-11-09 |
| Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex. Everolimus - Renal Angiomyolipoma | Phase 4 | Completed | Novartis Pharmaceuticals | 40 | 2018-11-09 | 2021-09-09 |
| Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis Sirolimus - Angiomyolipoma | Phase 4 | Completed | Fundacio Puigvert | 18 | 2008-10-01 | 2012-03-08 |
Tuberous Sclerosis (2) · Lymphangioleiomyomatosis (1)
Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Adipose Tissue (3) · Neoplasms, Connective and Soft Tissue (3) · Perivascular Epithelioid Cell Neoplasms (3) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Hamartoma (2) · Heredodegenerative Disorders, Nervous System (2) · Malformations of Cortical Development (2) · Malformations of Cortical Development, Group I (2) · Neoplasms, Multiple Primary (2) · Neoplastic Syndromes, Hereditary (2) · Nervous System Diseases (2)
Everolimus (2) · Sirolimus (1)
Novartis Pharmaceuticals (2) · Fundacio Puigvert (1)
China (1) · Taiwan (1)